BioSpace News Archive

Deals

Protein Motion Company Relay Therapeutics Files for $200 Million IPO

Relay Therapeutics was the No. 3 company in BioSpace’s NextGen Bio Class of 2018, Top 20 Life Science Startups to Watch in 2018.

June 25, 2020
·
3 min read
·
Mark Terry
BioCapital

CSL Behring Bolsters Gene Therapy Pipeline with uniQure’s Hemophilia B Treatment

CSL Behring bolstered its growing gene therapy portfolio with the acquisition of global rights to uniQure’s gene therapy program for hemophilia B that has a price tag of up to $2 billion.

June 25, 2020
·
3 min read
·
Alex Keown
BioCapital

Research Roundup: COVID-19 Immunity and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

June 25, 2020
·
5 min read
·
Mark Terry
Business

BioSpace Movers & Shakers, June 26

Biopharma and life sciences companies bolster their executive teams and board with these Movers & Shakers.

June 25, 2020
·
5 min read
·
Alex Keown
Policy

Novartis, Current and Former Units Agree to Pay More than $346 Million to Settle U.S. Bribery Charges

Novartis, Novartis Hellas and Alcon Inc. have agreed to pay a total of more than $346 million to settle bribery charges under the Foreign Corrupt Practices Act (FCPA), which is a U.S. anti-bribery law.

June 25, 2020
·
2 min read
·
Ellen Bombela
Policy

U.S. Government Alleges Regeneron Used Kickbacks to Boost Eylea Sales

Regeneron Pharmaceuticals said it will vigorously defend federal charges that it was involved in a kickback scheme to bolster sales of its blockbuster macular degeneration drug, Eylea.

June 25, 2020
·
3 min read
·
Alex Keown
Career Advice

Some Not So Common Interview Questions You Should Always Ask at the End of an Interview

Most job applicants don’t know about questions that they should ask at the end of an interview. Here are some not-so-common interview questions that you must remember to ask.

June 25, 2020
·
2 min read
·
Laura Brothers
Drug Development

Biopharma Update on the Novel Coronavirus: June 26

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 26, 2020.

June 25, 2020
·
3 min read
·
BioSpace Editorial Staff
Business

Sanofi Considering Additional Restructuring and Up to 1,000 Job Cuts

According to a brief report by Reuters, the drug company plans to hold meetings with staff representatives tomorrow and Monday of next week to describe a restructuring plan, according to four sources familiar with the matter.

June 25, 2020
·
5 min read
·
Mark Terry
Business

Regenerative Medicine Needs a New, Digital Supply Chain

The supply chain that exists for traditional pharmaceuticals is woefully insufficient for regenerative medicine, according to Robert Lechich, principal manufacturing and supply chain consultant for Global OT/IT – Quality Services.

June 25, 2020
·
5 min read
·
Gail Dutton